Skip to content

Dasatinib + Quercetin

Also called D+Q senolytic combination

Dasatinib is a tyrosine kinase inhibitor and quercetin a flavonoid.

  • TypeSmall molecule
  • FormOral
  • Researched forLongevity
Join Skool for the protocol

No partner carries Dasatinib + Quercetin yet.

The short version

  • Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
  • What the evidence isSmall human pilot trials exist and they are genuinely first-in-class.
  • What to watchNew breathlessness or chest pain, the fluid around lung pattern.

How Dasatinib + Quercetin works

Dasatinib is a tyrosine kinase inhibitor and quercetin a flavonoid; together they push senescent cells past the apoptotic threshold those cells normally resist. A genuinely different pharmacological model.

The pairing is not a designed combination. It is the answer to an experiment, and knowing that changes how you read every claim about it.

That is why there are two drugs and not one. Zhu 2015 found dasatinib effective against senescent human preadipocytes, which depend on ephrin-dependent tyrosine kinase signaling, and quercetin effective against senescent endothelial cells, which lean on a different survival network. Neither alone covered both.

  • Oral

On the goal map: Cellular senescence & senolytics (Longevity & healthspan)

Can you get Dasatinib + Quercetin?

No partner sells it, and this page won’t pretend otherwise.

Dasatinib is a leukemia chemotherapy drug. The senolytic protocol is a research setting, not a purchase — and I won't link a route to it.

Research on Dasatinib + Quercetin7 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Human clinical evidence

  • Small human pilot trials exist and they are genuinely first-in-class. An open-label pilot in idiopathic pulmonary fibrosis (14 patients) reported improved physical function.

  • These are tiny, uncontrolled, and short. They establish that senolysis can be measured in humans — which is a real milestone — not that it produces clinical benefit. Larger randomized trials are running.

Correlative data

  • Rather than continuously. The intermittent schedule is mechanistically motivated — you only need to be present long enough to kill cells that are already senescent.

  • Dasatinib is a prescription chemotherapy agent with real toxicity — myelosuppression, pleural effusion, bleeding risk and QT effects — and its record comes from leukemia patients, not healthy adults.

How the mechanism reads

  • Senescent cells stop dividing but do not die, and secrete an inflammatory mix (the SASP) that damages surrounding tissue. They accumulate with age, and clearing them extends healthspan in mice.

    Experimental, animal or cell
  • The pair is complementary by design: senescent cells resist apoptosis through several different survival pathways, and no single agent covers them all. Dasatinib inhibits tyrosine kinase-dependent survival signaling, quercetin hits BCL-2 family and PI3K pathways. Different cell types depend on different ones.

    Mechanistic
  • The mechanism predicts a specific risk: forcing apoptosis in a large cell population releases debris and inflammatory contents, and in someone with a heavy senescent burden that clearance load falls on the liver and kidneys.

    Mechanistic

Sources

  • Zhu Y, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 2015 · PMID 25754370
  • Justice JN, et al. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine 2019 · PMID 30616998
  • Zhu Y, et al. Orally-active, clinically-translatable senolytics restore alpha-Klotho in mice and humans. EBioMedicine 2022 · PMID 35292270
  • Zhu X, et al. Senolytic combination of dasatinib and quercetin protects against diabetic kidney disease by activating autophagy to alleviate podocyte dedifferentiation via the Notch pathway. International Journal of Molecular Medicine 2024 · PMID 38240118
  • Fang Y, et al. Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment. GeroScience 2023 · PMID 37296266
  • Wissler Gerdes EO, et al. Strategies for late phase preclinical and early clinical trials of senolytics. Mechanisms of Ageing and Development 2021 · PMID 34699859

Dasatinib + Quercetin safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Pregnancy, as dasatinib is a prescription kinase inhibitor with fetal harm.
  • Pulmonary arterial hypertension, or past pleural effusion.
  • Prolonged QT interval or taking QT-prolonging drugs.
  • A bleeding disorder or anticoagulant use, since dasatinib impairs platelets.
  • Low blood counts or taking acid-reducing drugs that alter its absorption.

What’s expected

  • Fatigue, headache and stomach upset for a few days.
  • Transient drops in blood counts.
  • Intermittent exposure, because cleared senescent cells do not return quickly.

Watch for

  • New breathlessness or chest pain, the fluid around lung pattern.
  • Bleeding, bruising or fever.
  • Swelling of the legs.

Labs that tell you it’s working

  • Complete Blood Count: dasatinib lowers neutrophils and platelets, so this is the main safety test.
  • Comprehensive Metabolic Panel: dasatinib is hepatically metabolized and can raise enzymes or lower sodium and phosphate.
  • hs-CRP: a rough proxy for senescence-driven inflammation.

Dasatinib (tyrosine kinase inhibitor) plus quercetin pushes senescent cells into apoptosis; the safety profile is that of an oncology drug. PMID 30616998 PMID 35292270

Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON

Dasatinib + Quercetin FAQ4 common questions

Is Dasatinib + Quercetin approved for human use?
No. Dasatinib + Quercetin is a research compound.
What is Dasatinib + Quercetin researched for?
Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
Which labs show whether it's doing anything?
Complete Blood Count; Comprehensive Metabolic Panel; hs-CRP: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Dasatinib + Quercetin: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Dasatinib + Quercetin is. Skool covers how it is run.

Free on this page

What Dasatinib + Quercetin is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Dasatinib + Quercetin is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Join Skool for the protocol